• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Investig . The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronav

tetano

Editor, Senior Moderator
Respir Investig


. 2021 Jan 28;S2212-5345(21)00008-3.
doi: 10.1016/j.resinv.2020.12.011. Online ahead of print.
The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia


Takahiro Fukushima[SUP] 1 [/SUP], Hiroki Kabata[SUP] 2 [/SUP], Ryo Yamamoto[SUP] 1 [/SUP], Tomohiro Suhara[SUP] 1 [/SUP], Yoshifumi Uwamino[SUP] 1 [/SUP], Yasushi Kondo[SUP] 1 [/SUP], Katsunori Masaki[SUP] 1 [/SUP], Hirofumi Kamata[SUP] 1 [/SUP], Hiromasa Nagata[SUP] 1 [/SUP], Koichiro Homma[SUP] 1 [/SUP], Yuko Kaneko[SUP] 1 [/SUP], Makoto Ishii[SUP] 1 [/SUP], Junichi Sasaki[SUP] 1 [/SUP], Hiroshi Morisaki[SUP] 1 [/SUP], Naoki Hasegawa[SUP] 1 [/SUP], Koichi Fukunaga[SUP] 1 [/SUP], Keio Donner Project Team



Affiliations

Abstract

The clinical course of coronavirus disease 2019 (COVID-19) varies from mild to critical. We retrospectively examined whether clinical and laboratory findings on admission could predict COVID-19 prognosis. Among various factors associated with COVID-19 severity, our results indicated that the real-time reverse transcription-polymerase chain reaction (RT-PCR) threshold cycle (Ct) values for severe acute respiratory syndrome coronavirus 2 were the most useful predictor of COVID-19 prognosis.

Keywords: COVID-19; Prognosis; SARS-CoV-2; Severity.
 
Back
Top Bottom